| Dr Nancy Fleurancois, MD | |
|
1221 Mercantile Ln Ste 102, Largo, MD 20774-5374 | |
| (301) 368-1500 | |
| Not Available |
| Full Name | Dr Nancy Fleurancois |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 1221 Mercantile Ln Ste 102, Largo, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063540045 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | C7.0003513 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
Depomed, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration issued a complete response letter to the New Drug Application for SEFELSA, Depomed's investigational, oral, twice daily formulation of gabapentin to treat moderate to severe vasomotor symptoms due to menopause.
A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine, Center for Vaccine Development and Global Health, has performed a clinical trial involving multiple hospitals that tested the effectiveness of applying a topical antibiotic known as mupirocin for prevention of Staphylococcus aureus infection in babies in the neonatal intensive care unit.
A genetic change in the dopamine transporter - one of the brain's dopamine-handling proteins - makes it behave as if amphetamine is present and "run backward," Vanderbilt University Medical Center investigators report this week in The Journal of Neuroscience.
Nonalcoholic steatohepatitis (NASH) occurs when fat builds up in the liver. This accumulation of fat damages the liver and leads to cirrhosis. NASH is rapidly increasing in the U.S. mainly related to the epidemics of obesity and diabetes.
› Verified 7 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
Depomed, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration issued a complete response letter to the New Drug Application for SEFELSA, Depomed's investigational, oral, twice daily formulation of gabapentin to treat moderate to severe vasomotor symptoms due to menopause.
A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine, Center for Vaccine Development and Global Health, has performed a clinical trial involving multiple hospitals that tested the effectiveness of applying a topical antibiotic known as mupirocin for prevention of Staphylococcus aureus infection in babies in the neonatal intensive care unit.
A genetic change in the dopamine transporter - one of the brain's dopamine-handling proteins - makes it behave as if amphetamine is present and "run backward," Vanderbilt University Medical Center investigators report this week in The Journal of Neuroscience.
Nonalcoholic steatohepatitis (NASH) occurs when fat builds up in the liver. This accumulation of fat damages the liver and leads to cirrhosis. NASH is rapidly increasing in the U.S. mainly related to the epidemics of obesity and diabetes.
› Verified 7 days ago
| Entity Name | Virginia Medical Alliance, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225083223 PECOS PAC ID: 0648262261 Enrollment ID: O20040401001342 |
News Archive
Depomed, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration issued a complete response letter to the New Drug Application for SEFELSA, Depomed's investigational, oral, twice daily formulation of gabapentin to treat moderate to severe vasomotor symptoms due to menopause.
A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine, Center for Vaccine Development and Global Health, has performed a clinical trial involving multiple hospitals that tested the effectiveness of applying a topical antibiotic known as mupirocin for prevention of Staphylococcus aureus infection in babies in the neonatal intensive care unit.
A genetic change in the dopamine transporter - one of the brain's dopamine-handling proteins - makes it behave as if amphetamine is present and "run backward," Vanderbilt University Medical Center investigators report this week in The Journal of Neuroscience.
Nonalcoholic steatohepatitis (NASH) occurs when fat builds up in the liver. This accumulation of fat damages the liver and leads to cirrhosis. NASH is rapidly increasing in the U.S. mainly related to the epidemics of obesity and diabetes.
› Verified 7 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275886418 PECOS PAC ID: 2466351093 Enrollment ID: O20121219000193 |
News Archive
Depomed, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration issued a complete response letter to the New Drug Application for SEFELSA, Depomed's investigational, oral, twice daily formulation of gabapentin to treat moderate to severe vasomotor symptoms due to menopause.
A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine, Center for Vaccine Development and Global Health, has performed a clinical trial involving multiple hospitals that tested the effectiveness of applying a topical antibiotic known as mupirocin for prevention of Staphylococcus aureus infection in babies in the neonatal intensive care unit.
A genetic change in the dopamine transporter - one of the brain's dopamine-handling proteins - makes it behave as if amphetamine is present and "run backward," Vanderbilt University Medical Center investigators report this week in The Journal of Neuroscience.
Nonalcoholic steatohepatitis (NASH) occurs when fat builds up in the liver. This accumulation of fat damages the liver and leads to cirrhosis. NASH is rapidly increasing in the U.S. mainly related to the epidemics of obesity and diabetes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nancy Fleurancois, MD 13005 Walkers Ln, Bowie, MD 20721-3288 Ph: (216) 337-0830 | Dr Nancy Fleurancois, MD 1221 Mercantile Ln Ste 102, Largo, MD 20774-5374 Ph: (301) 368-1500 |
News Archive
Depomed, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration issued a complete response letter to the New Drug Application for SEFELSA, Depomed's investigational, oral, twice daily formulation of gabapentin to treat moderate to severe vasomotor symptoms due to menopause.
A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine, Center for Vaccine Development and Global Health, has performed a clinical trial involving multiple hospitals that tested the effectiveness of applying a topical antibiotic known as mupirocin for prevention of Staphylococcus aureus infection in babies in the neonatal intensive care unit.
A genetic change in the dopamine transporter - one of the brain's dopamine-handling proteins - makes it behave as if amphetamine is present and "run backward," Vanderbilt University Medical Center investigators report this week in The Journal of Neuroscience.
Nonalcoholic steatohepatitis (NASH) occurs when fat builds up in the liver. This accumulation of fat damages the liver and leads to cirrhosis. NASH is rapidly increasing in the U.S. mainly related to the epidemics of obesity and diabetes.
› Verified 7 days ago
Dr. Lynn Anetta Thomas, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1221 Mercantile Ln, Kaiser Permanente Largo Medical Center, Largo, MD 20774 Phone: 301-618-5500 | |
Dr. Rupa Allam Varma, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1221 Mercantile Avenue, Largo, MD 20774 Phone: 301-618-5500 Fax: 301-618-5673 | |
Dr. Doreen Blake, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1450 Mercantile Ln, Suite 111, Largo, MD 20774 Phone: 301-925-7610 | |
Dr. Cielito M Aguinaldo, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1221 Mercantile Ln, Kaiser Permanente Largo Medical Center, Largo, MD 20774 Phone: 301-618-5500 | |
Dr. Surendra M Kumar, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1100 Mercantile Ln, Ste 135, Largo, MD 20774 Phone: 301-773-9700 | |
Dr. Jerry Wendell Mcconnell, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1221 Mercantile Lane, Largo, MD 20774 Phone: 301-618-5578 Fax: 301-618-5673 |